Cytori Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,122.00
4,953.00
4,838.00
4,656.00
2,689.00
3,671
Cost of Goods Sold (COGS) incl. D&A
3,421.00
2,940.00
3,186.00
2,715.00
2,543.00
2,373
Gross Income
3,701.00
2,013.00
1,652.00
1,941.00
146.00
1,298
SG&A Expense
42,122.00
37,464.00
31,427.00
28,371.00
22,865.00
16,379
EBIT
38,421.00
35,451.00
29,775.00
26,430.00
22,719.00
15,081
Unusual Expense
7,452.00
369.00
7,408.00
-
1,686.00
1,163
Non Operating Income/Expense
8,832.00
2,079.00
6,993.00
6,957.00
3,735.00
3,163
Interest Expense
3,996.00
4,371.00
3,379.00
2,592.00
2,049.00
1,922
Pretax Income
26,177.00
37,368.00
18,744.00
22,046.00
22,686.00
12,634
Consolidated Net Income
26,177.00
38,537.00
19,405.00
22,046.00
26,663.00
15,121
Net Income
26,177.00
38,537.00
19,405.00
22,046.00
26,663.00
15,121
Net Income After Extraordinaries
26,177.00
38,537.00
19,405.00
22,046.00
26,663.00
15,121
Net Income Available to Common
26,177.00
38,537.00
19,405.00
22,046.00
26,663.00
15,121
EPS (Basic)
58.50
72.00
21.00
12.80
8.20
1.74
Basic Shares Outstanding
451.90
538.90
938.60
1,729.10
3,239.00
8,692.60
EPS (Diluted)
57.93
71.51
20.67
12.75
8.23
1.74
Diluted Shares Outstanding
451.90
538.90
938.60
1,729.10
3,239.00
8,692.60
EBITDA
36,791.00
34,672.00
28,682.00
25,248.00
20,568.00
13,077
Non-Operating Interest Income
4.00
6.00
9.00
19.00
33.00
43
Equity in Affiliates (Pretax)
48.00
-
-
-
-
-
Other After Tax Income (Expense)
-
1,169.00
661.00
-
3,977.00
2,487
About Cytori Therapeutics
View Profile
